about
The Role of microRNAs in the Pathogenesis of Herpesvirus InfectionExtracellular vesicles from infected cells: potential for direct pathogenesisPotential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr VirusEpstein-Barr virus latent genesMolecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.Dissecting the regulation of EBV's BART miRNAs in carcinomas.Multiple functions are mediated by the miRNAs of Epstein-Barr virusThe Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.Identification of a polyomavirus microRNA highly expressed in tumors.Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses.Viral noncoding RNAs: more surprises.LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells.Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children.The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformationEBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.Divergent viral presentation among human tumors and adjacent normal tissues.Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy.Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and ApoptosisHuman viral oncogenesis: a cancer hallmarks analysisHuman and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma.The pathogenesis of Epstein-Barr virus persistent infection.Epstein-Barr virus and Burkitt lymphoma.Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomasThe role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV.EBV Persistence--Introducing the Virus.EBV Noncoding RNAs.Epstein-Barr virus: more than 50 years old and still providing surprises.A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis.Herpesvirus microRNAs for use in gene therapy immune-evasion strategies.Epstein-Barr viral microRNAs target caspase 3.
P2860
Q26748350-A98ACA3B-088D-41F1-9423-EDA9742AD3D1Q26779430-00F2426B-2FE7-4867-9E33-69CAAFB69A31Q26852071-696E27F7-1ABA-4CD8-B81C-1E99A2CCC263Q28082701-13DE681B-4F9A-4BFB-886F-09C344D73305Q30610963-9926B637-5E24-4712-88AF-BECDC5191B71Q33892295-353ED4AA-8632-4FDC-B993-482A623D3E8DQ34112079-8F46E479-7ED2-47E5-BC06-9DFB2200AAFEQ34973323-0B779758-26D3-4453-9FC3-99EA329D7CBEQ35070575-C3F2E05D-EA6E-41CA-B41E-3F7185C0BBA9Q35089995-A7088588-C37A-492C-A176-1CD82F6492DCQ35228726-9562BC0F-8C3A-47C9-AAA9-9FCCB6522A58Q35242466-A43F7EF3-F334-43A5-A151-472423BB0EFDQ35641559-79CE989B-C905-46ED-8185-49CE7CC54DD9Q35662292-9161B587-2931-4091-98CB-B41DED59F93CQ35711180-EE8C0C26-CF2B-4351-A3D6-76293D4423C4Q35875632-06EA6AF8-C557-489F-A932-D272E40F8ACFQ36052985-3E363EEE-37E2-4662-9D51-A79483B68C2DQ36105462-C7F1AE58-F8AB-441E-BB42-D298B439F1AAQ36346780-D99EC8ED-9317-450E-864C-4CBC23D7A08CQ36588894-6E621E1B-B4C2-46EE-87F2-BB29938CA179Q36650117-372066E4-AD1B-42A8-A3B3-7DF9FB1AEF44Q37034967-FB59585C-2122-4603-A4B0-697674E48696Q37225034-BF5748A8-C6F7-4EDF-BADC-01F7FC4F730FQ37272108-02248F1A-D602-4FE1-916B-64E06B17C4F9Q37534984-457179F3-F5CE-46A1-BDEC-D7C89CCE412EQ37593234-536F8D34-1D29-45D3-8088-B3FA7462AB2FQ37711147-518D9DBB-433F-4B2C-8700-0B3EDDDF4FAEQ37723512-93D04092-304C-4447-A022-5571732C077AQ38107595-861701DD-60C2-44D8-AF4D-D8ACB7007837Q38270680-37903A2B-A778-4A37-8D30-D49928DB26C2Q38289038-2EE23019-578C-4B5F-A37E-C1798D813D78Q38296711-A04A21FA-316D-4D6C-B8DC-D9BF8C2FFD37Q38440804-BCA9D4AF-90E9-4460-BF3D-505DEF0D71E8Q38563711-CD2DB11F-3345-4C43-A1EA-6F8B38D4CE4EQ38596344-75E4E162-A122-4778-9F1A-377DECA25A72Q38597243-23164420-AF61-4AB0-A654-37B968809756Q38968588-22E4DD3D-7628-4783-831A-667BE2F4885FQ38990489-F00DA438-66EF-4689-813D-6C21A7F5A309Q39293464-5E6389A9-C041-4727-B35D-A21CBA107E42Q39449661-730C2397-3FE6-4E9A-B5B9-C2610CE4FE1E
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Epstein-Barr virus maintains lymphomas via its miRNAs.
@en
type
label
Epstein-Barr virus maintains lymphomas via its miRNAs.
@en
prefLabel
Epstein-Barr virus maintains lymphomas via its miRNAs.
@en
P2093
P2860
P50
P356
P1433
P1476
Epstein-Barr virus maintains lymphomas via its miRNAs
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.71
P407
P577
2013-03-18T00:00:00Z